NCT07007390Not yet recruiting
Systems Biology of Amyotrophic Lateral Sclerosis (ALS)
Source: ClinicalTrials.gov · Last updated 5 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this observational study is to identify molecular features in multiple clinical samples and/or the patient environment that are associated with ALS. Participants will collect biological samples and answer questionnaires regarding their health at each appointment with their ALS practitioner.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 20 (estimated)
- First submitted
- 28 Mar 2025
- Start date
- 1 Jun 2025
- Primary completion date
- 1 Feb 2030
- Lead sponsor
- Viome
- Diseases
- ALS (motor neurone disease)
- NCT number
- NCT07007390
What you commit to
- Study type: Observational
- Planned participants: 20
- From 1 Jun 2025 to the primary completion date, 1 Feb 2030
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- Patient of Dr. Espíndola at UFSC
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.